tiprankstipranks
Trending News
More News >
Bausch Health Companies (TSE:BHC)
TSX:BHC
Canadian Market
Advertisement

Bausch Health Companies (BHC) Earnings Dates, Call Summary & Reports

Compare
165 Followers

Earnings Data

Report Date
Feb 25, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.75
Last Year’s EPS
1.62
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 29, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with multiple quarters of revenue and EBITDA growth, significant debt reduction, and strong product-level performance. However, some challenges remain in international markets and specific segments.
Company Guidance
During the Bausch Health Third Quarter 2025 Earnings Conference Call, the company reported continued strong operational performance with its 10th consecutive quarter of revenue and adjusted EBITDA growth, excluding Bausch + Lomb. The revenue for Bausch Health, excluding Bausch + Lomb, grew by 7% on a reported basis and 5% on an organic basis year-over-year, while adjusted EBITDA saw a 7% rise, reaching $773 million, despite an $81 million charge related to R&D acquisition. Excluding this charge, adjusted EBITDA grew by 18%. The company reduced its debt by approximately $600 million and raised its full-year guidance for revenue, adjusted EBITDA, and adjusted cash flow from operations. Notable achievements included double-digit growth in the Solta and Salix segments, with Solta experiencing a 25% increase and Salix a 12% increase in revenue. Additionally, product-level highlights included triple-digit growth for Cabtreo and Ryaltris and double-digit growth for Xifaxan and Thermage. The company also discussed a 7% revenue growth for Bausch + Lomb and improvements in financial priorities, including optimizing its capital structure and assessing options to unlock value for stakeholders.
Consecutive Revenue and EBITDA Growth
Bausch Health, excluding Bausch + Lomb, achieved its 10th consecutive quarter of year-over-year revenue and adjusted EBITDA growth, with a 7% increase in both metrics on a reported basis.
Debt Reduction
The company reduced its debt by approximately $600 million using cash on hand, showcasing strong financial management.
Solta and Salix Double-Digit Growth
Solta saw a 25% growth on a reported basis and 24% on an organic basis, while Salix delivered 12% growth on a reported basis and 11% on an organic basis.
Product-Level Achievements
Triple-digit growth for Cabtreo and Ryaltris, and double-digit growth for Xifaxan and Thermage were observed, indicating strong product performance.

Bausch Health Companies (TSE:BHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:BHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
1.75 / -
1.621
Oct 29, 2025
2025 (Q3)
1.48 / 1.62
1.5921.76% (+0.03)
Jul 30, 2025
2025 (Q2)
1.27 / 1.45
1.475-1.90% (-0.03)
Apr 30, 2025
2025 (Q1)
1.16 / 0.84
0.863-2.67% (-0.02)
Feb 19, 2025
2024 (Q4)
1.62 / 1.62
1.31123.65% (+0.31)
Oct 30, 2024
2024 (Q3)
1.42 / 1.59
1.487.57% (+0.11)
Jul 31, 2024
2024 (Q2)
1.20 / 1.48
1.09434.83% (+0.38)
May 02, 2024
2024 (Q1)
0.93 / 0.86
0.74715.53% (+0.12)
Feb 22, 2024
2023 (Q4)
1.38 / 1.31
1.419-7.61% (-0.11)
Nov 02, 2023
2023 (Q3)
1.26 / 1.48
1.08636.28% (+0.39)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:BHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 29, 2025
C$8.22C$9.25+12.53%
Jul 30, 2025
C$8.85C$8.17-7.68%
Apr 30, 2025
C$7.33C$7.31-0.27%
Feb 19, 2025
C$9.30C$10.18+9.46%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bausch Health Companies (TSE:BHC) report earnings?
Bausch Health Companies (TSE:BHC) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).
    What is Bausch Health Companies (TSE:BHC) earnings time?
    Bausch Health Companies (TSE:BHC) earnings time is at Feb 25, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:BHC EPS forecast?
          TSE:BHC EPS forecast for the fiscal quarter 2025 (Q4) is 1.75.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis